Chi-Yi Chen

Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial

Jyh‐Ming Liou, Yu-Jen Fang, Chieh‐Chang Chen et al. · The Lancet · 2016 · 197 citations

Bismuth Quadruple, Randomised Trial, Gastroenterology +3

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study

Pietro Lampertico, Scott Fung, Sang Hoon Ahn et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 139 citations

Hepatology, Viral Hepatitis, Pharmacology +8

Levofloxacin Sequential Therapy vs Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori: A Randomized Trial

Jyh‐Ming Liou, Ming-Jong Bair, Chieh‐Chang Chen et al. · The American Journal of Gastroenterology · 2016 · 47 citations

Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan

Chen‐Hua Liu, Po-Yueh Chen, Jyh-Jou Chen et al. · Hepatology International · 2021 · 31 citations

Hepatology, Hepatitis C, Viral Hepatitis +10

Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)

Chung‐Feng Huang, Hsueh‐Chou Lai, Chi-Yi Chen et al. · The American Journal of Gastroenterology · 2020 · 26 citations